BioNTech eyes approval for children′s COVID vaccines | News | DW : vimarsana.com

BioNTech eyes approval for children′s COVID vaccines | News | DW


Teenagers in US now able to get COVID-19 vaccines
Timeline for more vaccines
BioNTech and its partner Pfizer have already applied for authorization for the vaccine for 12 to 15 year-olds in the United States. Teenagers over the age of 16 can already take the two-shot vaccine that is available for adults.
Results from clinical tests should be available on a vaccine for children aged 5 to 12 by July. Figures for a jab for younger children, aged 6 months and upwards, should be on hand by September.
"If all goes well, as soon as the data is evaluated, we will be able to submit the application for approval of the vaccine for all children in the respective age group in different countries," he said.

Related Keywords

United States , Ugur Sahin , Pfizer , Der Spiegel , Biontech , Mrna , Comirnaty , Vaccine , Corona Virus , Covid 19 , Co Vid , ஒன்றுபட்டது மாநிலங்களில் , ஃபைசர் , டெர் ஸ்பீகல் , தடுப்பூசி , கொரோனா வைரஸ் , இணை வித் ,

© 2024 Vimarsana